Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/ Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

  1. Sureda, A.
  2. Canals, C.
  3. Arranz, R.
  4. Caballero, D.
  5. Ribera, J.M.
  6. Brune, M.
  7. Passweg, J.
  8. Martino, R.
  9. Valcárcel, D.
  10. Besalduch, J.
  11. Duarte, R.
  12. León, A.
  13. Pascual, M.J.
  14. García-Noblejas, A.
  15. Corral, L.L.
  16. Xicoy, B.
  17. Sierra, J.
  18. Schmitz, N.
Aldizkaria:
Haematologica

ISSN: 0390-6078,  1592-8721

Argitalpen urtea: 2012

Alea: 97

Zenbakia: 2

Orrialdeak: 310-317

Mota: Artikulua

DOI: 10.3324/HAEMATOL.2011.045757 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus